Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Stocks to Watch for May 21: Aditya Birla Capital, Dr Reddy's Lab, Jubilant Food, Bosch India and more
From Dr Reddy's Laboratories announcing the launch of its oral semaglutide biosimilar in India under the brand name Obeda to Whirlpool of India Ltd reporting a 32.7% year-on-year decline in net profit Q4, here are some stocks to track ahead of Thursday trading session.
Selling at higher levels turns 23,800 into key barrier for Nifty: Analysts
Benchmark Nifty closed lower last week. Analysts anticipate continued range-bound trading for Nifty this week. Trading strategies suggest buying on dips and selling on rallies within the 23,800-23,200 range. Specific stock recommendations include Indus Towers, Samvardhana Motherson International, Aditya Birla Capital, Sun Pharmaceutical Industries, and Arvind Limited. Investors are advised to consider these opportunities.
Aditya Birla Group to invest $500 million in Vodafone Idea as revival signal strengthens
Aditya Birla Group is injecting ₹4,730 crore into Vodafone Idea (Vi) through a preferential allotment, bolstering the telecom operator's financial standing. This capital infusion follows Kumar Mangalam Birla's return as chairman and aims to support Vi's efforts to compete with rivals Reliance Jio and Bharti Airtel.
Aditya Birla Health bets on wellness incentives to improve claims ratios
Aditya Birla Health wants to reward healthier customers, nudge those on the edge to be more consistent, and, lastly, intervene with high-risk customers to help them manage their health.
Gold, housing plays take a hit as Modi's austerity pitch rattles consumer-facing stocks
Jewellery and real estate stocks experienced a sharp decline after Prime Minister Modi urged financial restraint, advising citizens to postpone gold purchases and reduce discretionary travel. The comments, aimed at curbing fuel consumption amid geopolitical uncertainty and high energy costs, triggered an immediate market reaction in sectors tied to household spending.
Manipal Health acquires land, hospital in Mumbai’s Andheri for Rs 495 crore
Manipal Health Enterprises has made headlines by purchasing a hospital site in Andheri, Mumbai for Rs 495 crore. This acquisition is a slice of a broader Rs 908 crore deal, signaling a robust appetite for healthcare real estate among investors in major Indian cities.
Manipal Health buys Mumbai hospital asset for ₹495 crore in Andheri
Manipal Health Enterprises buys Andheri hospital asset in Mumbai for ₹495 crore from Khubchandani entities, deal registered May 6 2026, highlighting demand for healthcare real estate
Aditya Birla Capital Q4 FY26 Results | Wockhardt Q4 FY26 Results | Top Buzzing Stocks Today - Equitymaster
Aditya Birla Capital Q4 FY26 Results | Wockhardt Q4 FY26 Results | Top Buzzing Stocks TodayEquitymaster
Aditya Birla Capital Q4 FY26 Results | Wockhardt Q4 FY26 Results | Top Buzzing Stocks Today - Equitymaster
Aditya Birla Capital Q4 FY26 Results | Wockhardt Q4 FY26 Results | Top Buzzing Stocks TodayEquitymaster
India’s realty equity inflows hit record $30.7 billion between 2024-Q1 2026
Between 2024 and early 2026, India’s real estate landscape witnessed an astonishing influx of over $30 billion in equity capital, showcasing unprecedented investor enthusiasm. This surge, fueled by robust confidence and key structural enhancements, saw land, developmental opportunities, and commercial properties draw major funding.
Q4 Results LIVE Updates: DMart shares down 4%, ideaForge Technologies up 16%; Ambuja report today
Q4 Results LIVE Updates: Amubja Cements, Manappuram Finance, Godrej Properties, Aditya Birla Capital, Tata Technologies, KEI Industries, Jindal Stainless, BHEL, Aarti Industries, Sobha, Quess Corp, Tata Chemicals, Wockhardt, are among the companies reporting their earnings today. Also watch for earnings reactions from Avenue Supermarts, Kotak Mahindra Bank, CDSL, NSDL, Zen Technologies, Mazagon Dock and others. Watch this space for all the LIVE earnings reactions.
Growth Leaders: 10 midcap stocks with stellar 50%+ YoY sales gains
Several NSE midcap companies delivered strong growth in the December 2025 quarter, with sales rising over 50% year-on-year. Firms across sectors such as metals, real estate, energy and healthcare reported sharp demand-led expansion, highlighting strong business momentum and growth potential.